This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More Early Stocks in Motion

Updated from 8:25 a.m. EST

Biogen (BIIB - Get Report) said its general counsel resigned amid an SEC probe into his stock transactions. Thomas Bucknam, one of several company executives to sell shares around the time the company learned of problems that would lead to the withdrawal of multiple sclerosis drug Tysabri, left the company on Wednesday. Biogen refused to comment on the departure. The SEC is conducting an inquiry into Bucknum's sale of about 90,000 Biogen sales on Feb. 18. His lawyer reportedly described the resignation as an effort to remove a distraction. Biogen rose 20 cents to $39.51 Thursday morning. Its Tysarbi partner, Elan (ELN), rose 48 cents to $8.36.

Urban Outfitters (URBN - Get Report) said fourth-quarter earnings surged 72% from a year ago, beating Wall Street estimates. The specialty retailer earned $31.7 million, or 38 cents a share, in the quarter, compared with $18.4 million, or 22 cents a share, a year earlier. Sales rose 43% from a year ago to $251.6 million. Analysts surveyed by Thomson First Call had been forecasting earnings of 37 cents a share on sales of $251.4 million. The stock, which is up 7% this year and 159% since the start of 2004, recently added 46 cents, or 1%, to $47.98 in Instinet premarket trading. The stock fell $1.15 to $46.37 Thursday.

JetBlue (JBLU - Get Report) plans to sell $250 million in convertible debt due 2035. The company said the interest rate, conversion rate and offering price have yet to be determined. Morgan Stanley will lead the underwriters. The stock lost 63 cents to $18 Thursday morning.

Homestores (HOMS) said it swung to a fourth-quarter profit of $6 million, or 4 cents a share, compared with a year-ago loss of $12.1 million, or 10 cents a share. Revenues rose to $54.3 million from $51.9 last year. On a continuing operations basis, the company lost a penny a share in the quarter, matching estimates. The Thomson First Call consensus revenue estimate for the most recent quarter was $55.7 million. The stock lost 15 cents to $2.34 Thursday morning.

Coldwater Creek (CWTR) posted fourth-quarter earnings Wednesday of $11.4 million, or a split-adjusted 18 cents a share, on revenue that rose 20.9% to $204.1 million. Before the split, earnings in the latest quarter were 27 cents a share. According to Thomson First Call, analysts were looking for pre-split earnings of 25 cents a share on revenue of $198 million. The stock lost $1.48 to $30.75 Thursday morning.

Staar Surgical (STAA - Get Report) said its fourth quarter loss widened to $4.38 million, or 21 cents a share, from $3.52 million, or 19 cents a share, last year. Analysts surveyed by Thomson First Call had been expecting a loss of 15 cents a share in the quarter. Sales rose 9% to $14.0 million. The company said sales of domestic intraocular lenses remained challenging in the quarter. The stock fell $1.34 to $4.59 Thursday morning.

Andrx (ADRX) said after the bell on Wednesday that it earned $20.8 million, or 28 cents a share, in the fourth quarter ending Dec. 31, crushing the 12-cent analyst consensus. Total revenues increased 3% to $290 million compared to $281 million last year. Revenue for brand products increased 42.7% to $22.9 million compared to $16 million a year ago. The company attributed the big quarter to its distribution business, which generated a quarterly increase of $23.2 million in revenues. The stock gained 84 cents to $23.26 Thursday morning.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HOMS $0.34 -2.86%
ELN $0.00 0.00%
BIIB $274.99 0.00%
JBLU $19.79 0.00%
STAA $7.71 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs